English (United States)
 

All Studies

Sort by :
  Study Name Study Title Status Recruit. Contact
Infectious Diseases HCV-LU

Etude de la résistance du virus de l’Hépatite C au traitement

Past Done Contact info
Hematology PNH Registry

Paroxysmal Nocturnal Hemoglobinuria Registry

Past Done Contact info
Immunology MEASLES

Differential long-term effects of measles virus (MV) vaccination and wildtype infection with emphasis on the B cell ...

Past Done Contact info
Other MarLyBor

Novel biomarkers of Lyme Borreliosis

Past Done Contact info
Immunology NK-TAP

Interactions of natural killer (NK) cells with other immune cells in human and mouse TAP deficiency - Interactions entre les cellules « Nat...

Past Done Contact info
Allergy SYS-T-ACT

Applying systems immunology to the search for personalized biomarkers of clinical efficacy: Predicting the T cell ac...

Past Done Contact info
Respiratory Diseases EXPERT

EXPERT, EXPosurE Registry RiociguaT in patients with pulmona...

Past Done Contact info
Oncology / Cancer REFINE

REFINE: Regorafenib observational study in hepatocellular carcinoma

Current In Progress Contact info
Neurology / Stroke SESAME

Safety and Effectiveness of SOFIA™/SOFIA™ PLUS when used for direct aspiration as a first line treatment technique in patients suffer...

Future Pending Contact info
Respiratory Diseases PROOF Next

A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinic...

Current In Progress Contact info
Respiratory Diseases CQVM149B2302

A multicenter, randomized, 52-week, double-blind, parallelgroup,
active controlled study to compare the efficacy and safety of QVM149 wit...

Past Done Contact info
Oncology / Cancer CASSIOPEIA (Hovon 131)

Study of Daratumumab in combination with Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD) in the first Line treatment of transplant eli...

Past Done Contact info
Hematology HOVON 103 AML

A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition...

Future Pending Contact info
Oncology / Cancer Hovon 132 AML

Randomized study with a run-in dose-selection phase to assess the added value of
lenalidomide in combination with standard remission-indu...

Current Done Contact info
Hematology HOVON 95 MM

A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by...

Current Done Contact info
HIV HIVACAR

Evaluating a Combination of Immune-based Therapies to achieve a Functional Cure of HIV infection

Future Pending Contact info
HIV GP-41

Impact du sous-type de l’enveloppe VIH sur l’entrée, la transmission, la capacité ré...

Past Done Contact info
HIV PRT

Caractérisation des polymorphismes, des résistances et du tropisme des souches VIH au Luxembourg

Past Done Contact info
Oncology / Cancer PATSGO

Randomized multicentric Phase II study of prolonged adjuvant Temozolomide or "stop and go" in glioblastoma...

Past Done
Oncology / Cancer RACATREX

Randomized Phase II Study of CABAZITAXEL versus METHOTREXATE in patients with recurrent or metastatic squamous cell ...

Past Done
Oncology / Cancer FIELT 2

Treating lung cancer in non-smokers: the next step

Past Done
Hematology PASS

A non-interventional observational post authorisation safety study of subjects treated with lenalidomide.

Past Done
Other ENHANCE

A Prospective Long-term Evaluation of the Use of Permacol™ Biological Implant in the Repair of Complex Abdomin...

Past Done
Pain control Epipulse - prosp

Clinical prospective randomized Study with Crossover design, to compare epidural pulsed radiofrequency stimulation t...

Past Done
Other MIPAClux

motivational interviewing to increase physical activity behaviour in breast, endometrial and colorectal cancer patients in the Grand-Duchy of Lux...

Current In Progress Contact info
Per page: 5 10 25

Studies overview

This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.